EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Comparative efficacy of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for blood pressure lowering in adults with essential hypertension: a systematic review and meta-analysis

Manal E. Alotaibi, Roaa M. Alghamdi, Omar M. Khan, Yazan Shater, Abdullah Al-Aqla, Mohammed Al-Ahmadi, Ali Al-Harbi, Hassan Al-Hani, Mohammed Albagieh, Faris Al-Sahli

Annals of Middle Eastern Medicine · 21.06.2026 · 2 (2) · 195-204

DOI: 10.24911/amem.15-2738 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Middle Eastern Medicine, online erschienen am 19.06.2026. Verfasst von Manal E. Alotaibi und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are primary treatments for essential hypertension. Direct comparisons of their efficacy in blood pressure control are limited. This systematic review and meta-analysis aimed to assess and compare the safety and efficacy of these drugs in adults with essential hypertension.

Methods

Randomized controlled trials (RCTs) published from 2015 to 2025 were systematically reviewed using PubMed, MEDLINE, and Scopus. Studies comparing ACEIs and ARBs in adults with essential hypertension, focusing on changes in systolic blood pressure (SBP) and/or diastolic blood pressure (DBP), were included.

Results

Five RCTs including 852 participants were analyzed. There was no significant difference between ACEIs and ARBs in reducing SBP or achieving target blood pressure. The reduction in DBP was slightly greater with ACEIs. Safety profiles were similar; however, ACEIs were associated with a higher incidence of cough.

Conclusion

ACEIs and ARBs are equally effective in lowering SBP and managing blood pressure in adults with essential hypertension. Choice of therapy should be guided by tolerability, patient-specific factors, and vascular considerations rather than differences in blood pressure reduction.

Zitieren

APA

Alotaibi, M. E., Alghamdi, R. M., Khan, O. M., Shater, Y., Al-Aqla, A., Al-Ahmadi, M., Al-Harbi, A., Al-Hani, H., Albagieh, M., & Al-Sahli, F. (2026). Comparative efficacy of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for blood pressure lowering in adults with essential hypertension: a systematic review and meta-analysis. Annals of Middle Eastern Medicine, 2(2), 195-204. https://doi.org/10.24911/amem.15-2738

Vancouver

Alotaibi ME, Alghamdi RM, Khan OM, Shater Y, Al-Aqla A, Al-Ahmadi M, et al. Comparative efficacy of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for blood pressure lowering in adults with essential hypertension: a systematic review and meta-analysis. Annals of Middle Eastern Medicine. 2026;2(2):195-204. doi:10.24911/amem.15-2738

BibTeX
@article{Alotaibi2026,
  author = {Alotaibi, Manal E. and Alghamdi, Roaa M. and Khan, Omar M. and Shater, Yazan and Al-Aqla, Abdullah and Al-Ahmadi, Mohammed and Al-Harbi, Ali and Al-Hani, Hassan and Albagieh, Mohammed and Al-Sahli, Faris},
  title = {Comparative efficacy of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for blood pressure lowering in adults with essential hypertension: a systematic review and meta-analysis},
  journal = {Annals of Middle Eastern Medicine},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {195--204},
  doi = {10.24911/amem.15-2738}
}
Kostenlos starten →